Rafael Amado Insider Trading $ALLO Allogene Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rafael Amado.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rafael Amado. Rafael Amado is Chief Medical Officer in Adaptimmune Therapeutics PLC ($ADAP) and President, R & D in Adaptimmune Therapeutics PLC ($ADAP) and President, R&D in Adaptimmune Therapeutics PLC ($ADAP) and EVP of R&D and CMO in Allogene Therapeutics, Inc. ($ALLO).
Rafael Amado in Allogene Therapeutics, Inc.
Trading Symbol: ALLOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Rafael Amado: EVP of R&D and CMO
Holdings: 110,035 shares
Latest Transaction: Mar 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Rafael Amado in Allogene Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Sell | S | 38.05 | 2,798 | 106,471 | 110,035 | 112.8 K to 110 K (-2.48 %) |
Oct 08 2020 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Sell | S | 39.40 | 16,538 | 651,515 | 111,677 | 128.2 K to 111.7 K (-12.90 %) |
Mar 20 2020 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Option Exercise | A | 18.22 | 109,600 | 1,996,912 | 109,600 | |
Mar 20 2020 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Grant | A | 0.00 | 30,800 | 0 | 135,962 | 105.2 K to 136 K (+29.29 %) |
Sep 05 2019 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Option Exercise | A | 26.15 | 160,630 | 4,200,475 | 160,630 | |
Sep 05 2019 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Grant | A | 0.00 | 105,162 | 0 | 105,162 | 0 to 105.2 K |
Sep 05 2019 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Option Exercise | A | 26.15 | 160,630 | 4,200,475 | 160,630 | |
Sep 05 2019 | ALLO | Allogene Therapeut ... | Amado Rafael | EVP of R&D and CMO | Grant | A | 0.00 | 105,162 | 0 | 105,162 | 0 to 105.2 K |
Page: 1